Novo Nordisk AS (NVO)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$102.20

Buy

$103.50

arrow-down$-2.64 (-2.51%)

Prices updated at 22 Nov 2024, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.

S&P 500

0.53%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$103.22 - $101.51
	$148.15 - $94.73
	1.29
	531,366.82m
	34.92
	-
	6,185,447
	27.29
	4,607,626.72
	0.48
	4,510.00m
	US6701002056
	21.20
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Novo Nordisk AS (NVO)

$102.20

$103.50

arrow-down$-2.64 (-2.51%)

Don't miss out on our experts' free market insights - three times a week

Thank you. We've emailed you to confirm your subscription.